chr18:657653:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr18:657,653-673,578 |
hg38 | chr18:657,653-673,578 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.131 | squamous cell carcinoma | The gene expression levels of thymidylate synthase were significantly higher in ... | BeFree,CTD_human,LHGDN | 26031756 | Detail |
0.002 | brain ischemia | NA | GAD | Detail | |
<0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
0.003 | Uterine Cervical Neoplasm | NA | LHGDN | Detail | |
0.123 | cleft lip | NA | BeFree,CTD_human,GAD | Detail | |
0.123 | cleft palate | NA | BeFree,CTD_human,GAD | Detail | |
0.140 | Colonic Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
0.033 | colorectal carcinoma | Role of topoisomerase I and thymidylate synthase expression in sporadic colorect... | BeFree | 24332575 | Detail |
0.033 | colorectal carcinoma | Thymidylate synthase genetic polymorphisms and colorectal cancer risk: a meta-an... | BeFree | 24685603 | Detail |
0.033 | colorectal carcinoma | HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal ca... | BeFree | 25296971 | Detail |
0.033 | colorectal carcinoma | Arsenic trioxide (ATO) has been shown to suppress thymidylate synthase (TYMS) in... | BeFree | 25335113 | Detail |
0.033 | colorectal carcinoma | miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate syn... | BeFree | 25482885 | Detail |
0.033 | colorectal carcinoma | Statistically significant associations were observed between CRC risk and functi... | BeFree | 26108676 | Detail |
0.269 | Colorectal Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN,RGD | Detail | |
<0.001 | Crohn Disease | NA | BeFree | Detail | |
<0.001 | adenoid cystic carcinoma | NA | BeFree | Detail | |
0.003 | Cytomegalovirus Infections | NA | BeFree,LHGDN | Detail | |
<0.001 | Mental Depression | NA | BeFree | Detail | |
<0.001 | depressive disorder | NA | BeFree | Detail | |
0.003 | diarrhea | NA | BeFree,GAD | Detail | |
0.120 | Digestive System Neoplasms | NA | CTD_human | Detail | |
0.003 | Down syndrome | NA | BeFree,GAD | Detail | |
0.002 | drug allergy | NA | GAD | Detail | |
0.002 | Drug toxicity | NA | GAD | Detail | |
0.002 | Endometrial Neoplasms | NA | GAD | Detail | |
0.008 | Esophageal Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Exanthema | NA | BeFree | Detail | |
<0.001 | Fatigue | NA | BeFree | Detail | |
0.003 | Folic Acid Deficiency | NA | BeFree,GAD | Detail | |
0.002 | Gastrointestinal Diseases | NA | GAD | Detail | |
0.005 | Gastrointestinal Neoplasms | NA | GAD | Detail | |
0.003 | glioblastoma | NA | BeFree,LHGDN | Detail | |
0.120 | IgA glomerulonephritis | NA | CTD_human | Detail | |
0.003 | Graft-vs-Host Disease | NA | BeFree,GAD | Detail | |
0.122 | Head and Neck Neoplasms | NA | CTD_human,GAD | Detail | |
0.003 | congenital heart defects | NA | BeFree,GAD | Detail | |
0.005 | Hematological Disease | NA | GAD | Detail | |
<0.001 | Herpes Simplex Infections | NA | BeFree | Detail | |
<0.001 | HIV Infections | NA | BeFree | Detail | |
0.002 | homocystinuria | NA | GAD | Detail | |
0.002 | Hyperplasia | NA | GAD | Detail | |
<0.001 | intestinal obstruction | NA | BeFree | Detail | |
0.002 | Kidney Diseases | NA | GAD | Detail | |
0.002 | Laryngeal neoplasm | NA | GAD | Detail | |
0.015 | leukemia | NA | BeFree,GAD | Detail | |
0.002 | lymphoid leukemia | NA | GAD | Detail | |
0.004 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
0.003 | Leukemia, Myelocytic, Acute | NA | BeFree,GAD | Detail | |
<0.001 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
<0.001 | acute promyelocytic leukemia | Arsenic trioxide (ATO) has been shown to suppress thymidylate synthase (TYMS) in... | BeFree | 25335113 | Detail |
0.003 | leukopenia | NA | BeFree,GAD | Detail | |
<0.001 | lipodystrophy | NA | BeFree | Detail | |
0.003 | Liver neoplasms | NA | BeFree,GAD | Detail | |
0.003 | Chronic Obstructive Airway Disease | NA | BeFree,GAD | Detail | |
0.128 | Lung Neoplasms | NA | CTD_human,GAD,LHGDN | Detail | |
0.002 | Lupus Erythematosus, Systemic | NA | GAD | Detail | |
<0.001 | Lymphatic Metastasis | NA | BeFree | Detail | |
0.011 | lymphoma | NA | BeFree,GAD,LHGDN | Detail | |
0.123 | Lymphoma, Follicular | NA | BeFree,CTD_human,GAD | Detail | |
0.127 | Lymphoma, Non-Hodgkin | Our study suggests that variation in several OCM genes (CBS, FTHFD, SHMT1, TCN1,... | BeFree,CTD_human,GAD | 25384508 | Detail |
<0.001 | malaria | NA | BeFree | Detail | |
0.044 | Malignant neoplasm of stomach | Genetic polymorphisms in the microRNA binding-sites of the thymidylate synthase ... | BeFree,GAD | 24756984 | Detail |
0.044 | Malignant neoplasm of stomach | Raltitrexed is a specific inhibitor of thymidylate synthase (TS), which has been... | BeFree,GAD | 25109431 | Detail |
0.044 | Malignant neoplasm of stomach | Correlation between expression of thymidylate synthase and clinical outcome of a... | BeFree,GAD | 25185651 | Detail |
0.044 | Malignant neoplasm of stomach | These polymorphisms have been related to the risk of suffering different cancers... | BeFree,GAD | 26166093 | Detail |
0.080 | Mammary Neoplasms, Experimental | NA | RGD | Detail | |
<0.001 | melanoma | NA | BeFree | Detail | |
0.003 | meningioma | NA | BeFree,LHGDN | Detail | |
<0.001 | premature menopause | NA | BeFree | Detail | |
<0.001 | Mesothelioma | Downregulation of thymidylate synthase and E2F1 by arsenic trioxide in mesotheli... | BeFree | 25335113 | Detail |
<0.001 | Metabolic Diseases | The purpose of this study was to investigate if Z-TMS still shows potential for ... | BeFree | 26044878 | Detail |
0.002 | Metaplasia | NA | GAD | Detail | |
<0.001 | Mixed Salivary Gland Tumor | NA | BeFree | Detail | |
0.123 | cleft lip | We investigated two TYMS functional variants (a 28-bp tandem repeat in the promo... | BeFree | 23404871 | Detail |
<0.001 | Sporadic Breast Carcinoma | Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and ri... | BeFree | 24166930 | Detail |
0.123 | cleft palate | We investigated two TYMS functional variants (a 28-bp tandem repeat in the promo... | BeFree | 23404871 | Detail |
0.002 | Mouth Neoplasms | NA | GAD | Detail | |
0.008 | multiple myeloma | NA | BeFree,GAD | Detail | |
<0.001 | Xeroderma Pigmentosum, Complementation Group D | The germline polymorphisms studied were thymidylate synthase, (VNTR/5'UTR, 2R G&... | BeFree | 21570215 | Detail |
0.008 | Neoplasm Metastasis | NA | BeFree,LHGDN | Detail | |
0.120 | Neoplasm Recurrence, Local | NA | CTD_human | Detail | |
0.120 | nervous system disorder | NA | CTD_human | Detail | |
0.009 | Neural Tube Defects | NA | GAD | Detail | |
0.003 | neutropenia | NA | BeFree,GAD | Detail | |
0.005 | Bone necrosis | NA | GAD | Detail | |
0.003 | osteosarcoma | NA | BeFree,GAD | Detail | |
0.002 | ovarian carcinoma | Thirteen variants in the pyrimidine metabolism genes, DPYD, DPYS, PPAT, and TYMS... | BeFree | 25066213 | Detail |
<0.001 | Pustulosis of Palms and Soles | NA | BeFree | Detail | |
0.125 | Pancreatic Neoplasm | NA | CTD_human,GAD,LHGDN | Detail | |
<0.001 | pancreatitis | NA | BeFree | Detail | |
<0.001 | Peripheral neuropathy | NA | BeFree | Detail | |
0.002 | Pharyngeal Neoplasms | NA | GAD | Detail | |
<0.001 | Rothmund-Thomson syndrome | NA | BeFree | Detail | |
<0.001 | polyps | NA | BeFree | Detail | |
0.123 | Prostatic Neoplasms | NA | CTD_human,LHGDN | Detail | |
0.133 | Rectal Neoplasms | NA | BeFree,CTD_human,GAD | Detail | |
0.003 | retinoblastoma | NA | BeFree,GAD | Detail | |
<0.001 | Rett syndrome | NA | BeFree | Detail | |
0.080 | Splenomegaly | NA | RGD | Detail | |
0.153 | Stomach Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | stomatitis | NA | BeFree | Detail | |
0.002 | Cerebrovascular accident | NA | GAD | Detail | |
<0.001 | Giant Cell Arteritis | NA | BeFree | Detail | |
0.120 | Tongue Neoplasms | NA | CTD_human | Detail | |
0.120 | Adverse reaction to drug | NA | CTD_human | Detail | |
0.002 | Venous Thrombosis | NA | GAD | Detail | |
<0.001 | xeroderma pigmentosum | NA | BeFree | Detail | |
<0.001 | Arachnoid Cysts | NA | BeFree | Detail | |
0.002 | Helicobacter Infections | NA | GAD | Detail | |
0.002 | B-Cell Lymphomas | NA | GAD | Detail | |
0.003 | diffuse large B-cell lymphoma | NA | BeFree,GAD | Detail | |
0.001 | Lymphoma, Large-Cell, Follicular | NA | BeFree | Detail | |
0.003 | T-Cell Lymphoma | NA | BeFree,GAD | Detail | |
0.008 | spina bifida | NA | BeFree,GAD | Detail | |
0.005 | Central Nervous System Neoplasms | NA | GAD | Detail | |
<0.001 | Ovarian Failure, Premature | NA | BeFree | Detail | |
0.002 | Arthritis, Reactive | NA | GAD | Detail | |
<0.001 | acute leukemia | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of lung | NA | BeFree | Detail | |
0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
0.005 | Migraine Disorders | NA | BeFree,GAD | Detail | |
0.001 | Adenocarcinoma of rectum | NA | BeFree | Detail | |
0.003 | Adenocarcinoma of lung (disorder) | Arsenic trioxide (ATO) has been shown to suppress thymidylate synthase (TYMS) in... | BeFree | 25335113 | Detail |
<0.001 | esophageal carcinoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of nasopharynx | NA | BeFree | Detail | |
<0.001 | Malignant tumor of peritoneum | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
0.002 | Aortic Aneurysm, Abdominal | NA | GAD | Detail | |
<0.001 | Agenesis of corpus callosum | NA | BeFree | Detail | |
<0.001 | Tumor Progression | NA | BeFree | Detail | |
<0.001 | thymic carcinoma | NA | BeFree | Detail | |
<0.001 | adenosquamous carcinoma | NA | BeFree | Detail | |
<0.001 | Adenomatous Polyps | NA | BeFree | Detail | |
0.003 | Carcinoma, Neuroendocrine | NA | BeFree,LHGDN | Detail | |
0.123 | Neuroendocrine Tumors | NA | BeFree,CTD_human,LHGDN | Detail | |
0.120 | Hyperammonemia | NA | CTD_human | Detail | |
0.002 | Neurotoxicity Syndromes | NA | GAD | Detail | |
0.003 | pancreatic carcinoma | NA | BeFree | Detail | |
<0.001 | Cancer of Nasopharynx | NA | BeFree | Detail | |
<0.001 | islet cell tumor | NA | BeFree | Detail | |
0.016 | Malignant neoplasm of lung | Diagnostic tissue-samples were used to assess TS-expression by immunohistochemis... | BeFree,GAD | 25250715 | Detail |
<0.001 | Mucosa-Associated Lymphoid Tissue Lymphoma | NA | BeFree | Detail | |
<0.001 | Carcinoma, Small Cell | NA | BeFree | Detail | |
<0.001 | Turcot syndrome (disorder) | NA | BeFree | Detail | |
<0.001 | Xeroderma Pigmentosum, Complementation Group D | NA | BeFree | Detail | |
0.002 | Hemifacial Spasm | NA | GAD | Detail | |
<0.001 | Stage III Colon Cancer | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of stomach stage IV | NA | BeFree | Detail | |
<0.001 | Metastatic Renal Cell Cancer | NA | BeFree | Detail | |
0.001 | gastric adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Non-small cell lung cancer metastatic | NA | BeFree | Detail | |
0.007 | Cancer of Head and Neck | NA | BeFree,GAD | Detail | |
0.001 | Squamous cell carcinoma of esophagus | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma Of Esophagus | NA | BeFree | Detail | |
<0.001 | Conventional (Clear Cell) Renal Cell Carcinoma | NA | BeFree | Detail | |
0.001 | Solid tumour | 5-Fluorouracil (5-FU), the mainstay of solid tumor chemotherapy over the past 40... | BeFree | 24434920 | Detail |
<0.001 | stage, rectal cancer | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of oropharynx | TYMS-expression in HPV-positive OPC tissues was significantly higher than in HPV... | BeFree | 25423960 | Detail |
<0.001 | cervix carcinoma | NA | BeFree | Detail | |
0.002 | Inflammatory disease of mucous membrane | NA | GAD | Detail | |
<0.001 | pleomorphic carcinoma | The gene expression levels of thymidylate synthase were significantly higher in ... | BeFree | 26031756 | Detail |
<0.001 | Adenocarcinoma of colon | NA | BeFree | Detail | |
0.005 | Malignant neoplasm of pancreas | NA | BeFree,GAD | Detail | |
<0.001 | intracranial meningioma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
<0.001 | Hematologic Neoplasms | NA | BeFree | Detail | |
<0.001 | endometrial carcinoma | NA | BeFree | Detail | |
0.004 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
0.002 | dementia | NA | GAD | Detail | |
<0.001 | Recurrent tumor | NA | BeFree | Detail | |
0.002 | Retinal Neoplasms | NA | GAD | Detail | |
0.024 | Malignant neoplasm of esophagus | NA | BeFree,GAD | Detail | |
0.005 | Methotrexate poisoning | NA | GAD | Detail | |
0.002 | Carcinogenesis | The role of folic acid in carcinogenesis may be modulated by polymorphism C677T ... | BeFree | 25341694 | Detail |
<0.001 | Islets of Langerhans hyperplasia | NA | BeFree | Detail | |
0.005 | hyperhomocysteinemia | NA | BeFree,GAD | Detail | |
<0.001 | prostate carcinoma | NA | BeFree | Detail | |
0.002 | Epithelial ovarian cancer | Thirteen variants in the pyrimidine metabolism genes, DPYD, DPYS, PPAT, and TYMS... | BeFree | 25066213 | Detail |
<0.001 | Progressive Neoplastic Disease | NA | BeFree | Detail | |
<0.001 | Refractory cancer | Since high levels of TS have been linked to clinical resistance to pemetrexed in... | BeFree | 25301686 | Detail |
<0.001 | Locally Advanced Malignant Neoplasm | NA | BeFree | Detail | |
0.007 | breast carcinoma | Association between polymorphisms in the thymidylate synthase gene and risk of b... | BeFree | 25366766 | Detail |
0.007 | breast carcinoma | A number of these SNPs, specifically in genes including MTR, MTRR, SHMT1, TYMS a... | BeFree | 25598430 | Detail |
0.004 | Carcinoma of lung | Diagnostic tissue-samples were used to assess TS-expression by immunohistochemis... | BeFree | 25250715 | Detail |
0.003 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
0.002 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
0.002 | Pregnancy loss | NA | GAD | Detail | |
0.013 | colon carcinoma | Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of th... | BeFree | 26208739 | Detail |
0.014 | stomach carcinoma | Genetic polymorphisms in the microRNA binding-sites of the thymidylate synthase ... | BeFree | 24756984 | Detail |
0.014 | stomach carcinoma | Raltitrexed is a specific inhibitor of thymidylate synthase (TS), which has been... | BeFree | 25109431 | Detail |
0.014 | stomach carcinoma | Correlation between expression of thymidylate synthase and clinical outcome of a... | BeFree | 25185651 | Detail |
0.014 | stomach carcinoma | These polymorphisms have been related to the risk of suffering different cancers... | BeFree | 26166093 | Detail |
0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of kidney | NA | BeFree | Detail | |
<0.001 | adult acute lymphocytic leukemia | NA | BeFree | Detail | |
0.001 | malignant pleural mesothelioma | NA | BeFree | Detail | |
<0.001 | Myelosuppression | NA | BeFree | Detail | |
<0.001 | Colorectal cancer recurrent | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of lung, stage I | NA | BeFree | Detail | |
<0.001 | Acute GVH disease | NA | BeFree | Detail | |
<0.001 | Advanced cancer | NA | BeFree | Detail | |
0.123 | ovarian neoplasm | NA | CTD_human,LHGDN | Detail | |
<0.001 | cancer recurrence | NA | BeFree | Detail | |
<0.001 | cancer regression | NA | BeFree | Detail | |
0.007 | breast carcinoma | In this case-control study, we investigated the association between MTHFR C677T ... | BeFree | 22134752 | Detail |
<0.001 | Bone marrow toxicity | NA | BeFree | Detail | |
0.004 | Colorectal cancer metastatic | We previously reported that the clinical response and prognosis of metastatic co... | BeFree | 25198900 | Detail |
0.004 | Colorectal cancer metastatic | The TYMS 2R/3G, 3C/3G or 3G/3G promoter variants were associated with worse PFS ... | BeFree | 25677447 | Detail |
0.004 | Acute lymphocytic leukemia | Children with ALL (n = 96) were screened for GCPII C1561T, RFC1 G80A, cSHMT C142... | BeFree | 22838948 | Detail |
<0.001 | neuroblastoma | The aim of this study was to investigate whether the genetic polymorphisms MTHFR... | BeFree | 24771227 | Detail |
<0.001 | Vascular occlusion | NA | BeFree | Detail | |
<0.001 | Gastrooesophageal cancer | Germline polymorphisms of DPYD, TYMS and GSTP1 have a significant effect on toxi... | BeFree | 25677447 | Detail |
0.022 | Precursor Cell Lymphoblastic Leukemia Lymphoma | Children with ALL (n = 96) were screened for GCPII C1561T, RFC1 G80A, cSHMT C142... | BeFree | 22838948 | Detail |
0.003 | retinoblastoma | A case-control study of 72 retinoblastoma cases and 98 cancer-free children cont... | BeFree | 20310006 | Detail |
0.004 | Malignant neoplasm of ovary | NA | BeFree,GAD | Detail | |
<0.001 | Central neuroblastoma | The aim of this study was to investigate whether the genetic polymorphisms MTHFR... | BeFree | 24771227 | Detail |
0.035 | Malignant neoplasm of breast | In this case-control study, we investigated the association between MTHFR C677T ... | BeFree | 22134752 | Detail |
<0.001 | Stage IV Pancreatic Cancer | NA | BeFree | Detail | |
0.001 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
<0.001 | sarcoma | NA | BeFree | Detail | |
0.004 | Adenoma of large intestine | NA | BeFree,GAD | Detail | |
0.002 | Adenocarcinoma of large intestine | NA | BeFree | Detail | |
<0.001 | Thymoma, type C | NA | BeFree | Detail | |
<0.001 | gastric cardia adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Sporadic Breast Carcinoma | Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk ... | BeFree | 24166930 | Detail |
<0.001 | Marginal Zone B-Cell Lymphoma | NA | BeFree | Detail | |
<0.001 | Epithelioma | NA | BeFree | Detail | |
<0.001 | renal carcinoma | NA | BeFree | Detail | |
<0.001 | Metastatic Carcinoma | We have designed four gene molecular beacon (MB) probes for multiplex quantitati... | BeFree | 24935362 | Detail |
0.136 | Mammary Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | Xenograft Model | NA | BeFree | Detail | |
0.112 | colorectal cancer | Role of topoisomerase I and thymidylate synthase expression in sporadic colorect... | BeFree,GAD | 24332575 | Detail |
0.112 | colorectal cancer | Thymidylate synthase genetic polymorphisms and colorectal cancer risk: a meta-an... | BeFree,GAD | 24685603 | Detail |
0.112 | colorectal cancer | HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal ca... | BeFree,GAD | 25296971 | Detail |
0.112 | colorectal cancer | Arsenic trioxide (ATO) has been shown to suppress thymidylate synthase (TYMS) in... | BeFree,GAD | 25335113 | Detail |
0.112 | colorectal cancer | miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate syn... | BeFree,GAD | 25482885 | Detail |
0.112 | colorectal cancer | Statistically significant associations were observed between CRC risk and functi... | BeFree,GAD | 26108676 | Detail |
<0.001 | Rectal Tumors | NA | BeFree | Detail | |
0.002 | Rash and Dermatitis Adverse Event Associated with Chemoradiation | NA | BeFree | Detail | |
<0.001 | Glioblastoma multiforme | NA | BeFree | Detail | |
<0.001 | uterine corpus cancer | NA | BeFree | Detail | |
0.003 | coronary artery disease | NA | BeFree,GAD | Detail | |
0.022 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,GAD,LHGDN | Detail | |
0.129 | liver carcinoma | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | Nasopharyngeal carcinoma | NA | BeFree | Detail | |
0.003 | Prostatic Hyperplasia | NA | LHGDN | Detail | |
<0.001 | Stage III Colon Cancer AJCC v7 | NA | BeFree | Detail | |
<0.001 | Progressive cGVHD | NA | BeFree | Detail | |
<0.001 | Thymus Neoplasms | NA | BeFree | Detail | |
0.005 | Spontaneous abortion | NA | GAD,LHGDN | Detail | |
<0.001 | acute pancreatitis | NA | BeFree | Detail | |
0.031 | adenocarcinoma | The gene expression levels of thymidylate synthase were significantly higher in ... | BeFree,GAD,LHGDN | 26031756 | Detail |
0.003 | adenoma | NA | BeFree,GAD | Detail | |
0.121 | anemia | NA | BeFree,CTD_human | Detail | |
0.026 | rheumatoid arthritis | Therapeutic outcome of rheumatoid arthritis (RA) patients treated with methotrex... | BeFree,GAD,LHGDN | 25279663 | Detail |
0.002 | Barrett esophagus | NA | GAD | Detail | |
0.003 | Behcet Syndrome | NA | BeFree,GAD | Detail | |
0.008 | Malignant neoplasm of urinary bladder | NA | BeFree,GAD | Detail | |
0.080 | Bladder Neoplasm | NA | BeFree,RGD | Detail | |
0.002 | Bone neoplasms | NA | GAD | Detail | |
0.120 | Brain Diseases | NA | CTD_human | Detail | |
0.035 | Malignant neoplasm of breast | Association between polymorphisms in the thymidylate synthase gene and risk of b... | BeFree,GAD | 25366766 | Detail |
0.035 | Malignant neoplasm of breast | A number of these SNPs, specifically in genes including MTR, MTRR, SHMT1, TYMS a... | BeFree,GAD | 25598430 | Detail |
0.014 | Malignant tumor of colon | NA | BeFree,GAD | Detail | |
<0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
0.007 | Rectal Carcinoma | NA | BeFree,GAD | Detail | |
0.013 | Non-small cell lung carcinoma | In addition, relationships between EGFR mutation status and the immunohistochemi... | BeFree,GAD | 24405586 | Detail |
0.013 | Non-small cell lung carcinoma | Seventy-six Chinese patients with NSCLC were enrolled in the study to investigat... | BeFree,GAD | 24762590 | Detail |
0.013 | Non-small cell lung carcinoma | This study was aimed to establish a novel method to simultaneously detect expres... | BeFree,GAD | 24935362 | Detail |
0.013 | Non-small cell lung carcinoma | Since high levels of TS have been linked to clinical resistance to pemetrexed in... | BeFree,GAD | 25301686 | Detail |
<0.001 | renal cell carcinoma | NA | BeFree | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
The gene expression levels of thymidylate synthase were significantly higher in PPC and SCC as compa... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Role of topoisomerase I and thymidylate synthase expression in sporadic colorectal cancer: associati... | DisGeNET | Detail |
Thymidylate synthase genetic polymorphisms and colorectal cancer risk: a meta-analysis. | DisGeNET | Detail |
HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to t... | DisGeNET | Detail |
Arsenic trioxide (ATO) has been shown to suppress thymidylate synthase (TYMS) in lung adenocarcinoma... | DisGeNET | Detail |
miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal ... | DisGeNET | Detail |
Statistically significant associations were observed between CRC risk and functionally defined candi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Arsenic trioxide (ATO) has been shown to suppress thymidylate synthase (TYMS) in lung adenocarcinoma... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our study suggests that variation in several OCM genes (CBS, FTHFD, SHMT1, TCN1, and TYMS) may influ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Genetic polymorphisms in the microRNA binding-sites of the thymidylate synthase gene predict risk an... | DisGeNET | Detail |
Raltitrexed is a specific inhibitor of thymidylate synthase (TS), which has been considered as a pot... | DisGeNET | Detail |
Correlation between expression of thymidylate synthase and clinical outcome of advanced gastric canc... | DisGeNET | Detail |
These polymorphisms have been related to the risk of suffering different cancers, for example leukem... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Downregulation of thymidylate synthase and E2F1 by arsenic trioxide in mesothelioma. | DisGeNET | Detail |
The purpose of this study was to investigate if Z-TMS still shows potential for the prevention of me... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We investigated two TYMS functional variants (a 28-bp tandem repeat in the promoter enhancer region ... | DisGeNET | Detail |
Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breas... | DisGeNET | Detail |
We investigated two TYMS functional variants (a 28-bp tandem repeat in the promoter enhancer region ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The germline polymorphisms studied were thymidylate synthase, (VNTR/5'UTR, 2R G>C single nucleoti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Thirteen variants in the pyrimidine metabolism genes, DPYD, DPYS, PPAT, and TYMS, also interacted si... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Arsenic trioxide (ATO) has been shown to suppress thymidylate synthase (TYMS) in lung adenocarcinoma... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Diagnostic tissue-samples were used to assess TS-expression by immunohistochemistry (IHC) and mRNA-e... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
5-Fluorouracil (5-FU), the mainstay of solid tumor chemotherapy over the past 40 years, induces grad... | DisGeNET | Detail |
NA | DisGeNET | Detail |
TYMS-expression in HPV-positive OPC tissues was significantly higher than in HPV-negative ones in bo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The gene expression levels of thymidylate synthase were significantly higher in PPC and SCC as compa... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The role of folic acid in carcinogenesis may be modulated by polymorphism C677T in MTHFR and tandem ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Thirteen variants in the pyrimidine metabolism genes, DPYD, DPYS, PPAT, and TYMS, also interacted si... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Since high levels of TS have been linked to clinical resistance to pemetrexed in NSCLC, herein we in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association between polymorphisms in the thymidylate synthase gene and risk of breast cancer in a Me... | DisGeNET | Detail |
A number of these SNPs, specifically in genes including MTR, MTRR, SHMT1, TYMS and SLC19A1, were ass... | DisGeNET | Detail |
Diagnostic tissue-samples were used to assess TS-expression by immunohistochemistry (IHC) and mRNA-e... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase i... | DisGeNET | Detail |
Genetic polymorphisms in the microRNA binding-sites of the thymidylate synthase gene predict risk an... | DisGeNET | Detail |
Raltitrexed is a specific inhibitor of thymidylate synthase (TS), which has been considered as a pot... | DisGeNET | Detail |
Correlation between expression of thymidylate synthase and clinical outcome of advanced gastric canc... | DisGeNET | Detail |
These polymorphisms have been related to the risk of suffering different cancers, for example leukem... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In this case-control study, we investigated the association between MTHFR C677T and A1298C, TYMS 5'-... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We previously reported that the clinical response and prognosis of metastatic colorectal cancer (mCR... | DisGeNET | Detail |
The TYMS 2R/3G, 3C/3G or 3G/3G promoter variants were associated with worse PFS in the CRC (HR = 2.0... | DisGeNET | Detail |
Children with ALL (n = 96) were screened for GCPII C1561T, RFC1 G80A, cSHMT C1420T, TYMS 5´-UTR 2R3R... | DisGeNET | Detail |
The aim of this study was to investigate whether the genetic polymorphisms MTHFR C677T and A1298C, M... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Germline polymorphisms of DPYD, TYMS and GSTP1 have a significant effect on toxicity and clinical ou... | DisGeNET | Detail |
Children with ALL (n = 96) were screened for GCPII C1561T, RFC1 G80A, cSHMT C1420T, TYMS 5´-UTR 2R3R... | DisGeNET | Detail |
A case-control study of 72 retinoblastoma cases and 98 cancer-free children controls was performed t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of this study was to investigate whether the genetic polymorphisms MTHFR C677T and A1298C, M... | DisGeNET | Detail |
In this case-control study, we investigated the association between MTHFR C677T and A1298C, TYMS 5'-... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast c... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We have designed four gene molecular beacon (MB) probes for multiplex quantitative real-time polymer... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Role of topoisomerase I and thymidylate synthase expression in sporadic colorectal cancer: associati... | DisGeNET | Detail |
Thymidylate synthase genetic polymorphisms and colorectal cancer risk: a meta-analysis. | DisGeNET | Detail |
HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to t... | DisGeNET | Detail |
Arsenic trioxide (ATO) has been shown to suppress thymidylate synthase (TYMS) in lung adenocarcinoma... | DisGeNET | Detail |
miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal ... | DisGeNET | Detail |
Statistically significant associations were observed between CRC risk and functionally defined candi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The gene expression levels of thymidylate synthase were significantly higher in PPC and SCC as compa... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Therapeutic outcome of rheumatoid arthritis (RA) patients treated with methotrexate (MTX) can be mod... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association between polymorphisms in the thymidylate synthase gene and risk of breast cancer in a Me... | DisGeNET | Detail |
A number of these SNPs, specifically in genes including MTR, MTRR, SHMT1, TYMS and SLC19A1, were ass... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In addition, relationships between EGFR mutation status and the immunohistochemical expression of DP... | DisGeNET | Detail |
Seventy-six Chinese patients with NSCLC were enrolled in the study to investigate mRNA expression pr... | DisGeNET | Detail |
This study was aimed to establish a novel method to simultaneously detect expression of four genes, ... | DisGeNET | Detail |
Since high levels of TS have been linked to clinical resistance to pemetrexed in NSCLC, herein we in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs16430 dbSNP
- Genome
- hg19
- Position
- chr18:657,653-673,578
- Variant Type
- snv
Genome browser